Also known as: N-trifluoroacetyladriamycin-14-valerate; Valstar; AD 32
Valrubicin is a high-purity Active Pharmaceutical Ingredient supplied by Mediocon Inc conforming to IP / BP / EP / USP specifications. Manufactured at our GMP-certified facility in Aurangabad, Maharashtra, India.
Valrubicin is a semi-synthetic analogue of doxorubicin used as intravesical therapy for BCG-refractory bladder carcinoma in situ (CIS). It penetrates bladder cells and inhibits topoisomerase II, disrupting nucleoside incorporation into DNA and RNA.
Key Features
Applications
Why Choose Mediocon
| Parameter | Specification |
|---|---|
| Assay | NLT 98.0% |
| Loss on Drying | NMT 0.5% |
| Heavy Metals | NMT 20 ppm |
| Residue on Ignition | NMT 0.1% |
| Microbial Limits | Complies with pharmacopoeia |
| Identification | IR, HPLC Compliant |
| Batch No. | VRB/24033049 |
| Mfg Date | MAR 2026 |
| Exp Date | FEB 2031 |
| Packing | 25 kg HDPE drums / as per requirement |